Trials / Sponsors / GigaGen, Inc.
GigaGen, Inc.
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hep Hepatitis B Virus Infection | Phase 1 | 2024-11-13 |
| Recruiting | A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tu Advanced or Metastatic Solid Tumor Malignancies | Phase 1 | 2024-05-08 |
| Terminated | Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients COVID-19 | Phase 1 | 2021-05-24 |